{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T01:05:14Z","timestamp":1792458314666,"version":"4.5.0"},"reference-count":10,"publisher":"Scientific Scholar","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Orthopaedics"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.jor.2026.03.039","type":"journal-article","created":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T07:01:24Z","timestamp":1775026884000},"page":"222-229","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Impact of IL-23 inhibition versus methotrexate on select major fracture risk and progression to joint arthroplasty in psoriatic patients"],"prefix":"10.25259","volume":"76","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-0983-0219","authenticated-orcid":false,"given":"Dion","family":"Birhiray","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-7412-9802","authenticated-orcid":false,"given":"Ben","family":"Gratz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5422-637X","authenticated-orcid":false,"given":"Stephen","family":"Rossettie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo","family":"Tjahjono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Addisu","family":"Mesfin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10894","reference":[{"issue":"3","key":"10.1016\/j.jor.2026.03.039_bib1","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.jaci.2017.07.004","article-title":"Psoriasis pathogenesis and the development of novel targeted immune therapies","volume":"140","author":"Hawkes","year":"2017","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.jor.2026.03.039_bib2","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1590\/abd1806-4841.20153038","article-title":"Psoriasis: classical and emerging comorbidities","volume":"90","author":"Oliveira","year":"2015","journal-title":"An Bras Dermatol"},{"issue":"5","key":"10.1016\/j.jor.2026.03.039_bib3","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1136\/annrheumdis-2016-210441","article-title":"The risk of fracture among patients with psoriatic arthritis and psoriasis: a population-based study","volume":"76","author":"Ogdie","year":"2017","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"10.1016\/j.jor.2026.03.039_bib4","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1007\/s00223-017-0380-2","article-title":"Altered bone remodeling in psoriatic disease: new insights and future directions","volume":"102","author":"Paine","year":"2018","journal-title":"Calcif Tissue Int"},{"issue":"2","key":"10.1016\/j.jor.2026.03.039_bib5","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.rdc.2010.03.003","article-title":"Bone damage in rheumatoid arthritis: mechanistic insights and approaches to prevention","volume":"36","author":"Karmakar","year":"2010","journal-title":"Rheum Dis Clin N Am"},{"issue":"4","key":"10.1016\/j.jor.2026.03.039_bib6","first-page":"CD010498","article-title":"Methotrexate for psoriasis","volume":"2019","author":"da","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.jor.2026.03.039_bib7","doi-asserted-by":"crossref","DOI":"10.1111\/cts.13706","article-title":"Risankizumab: mechanism of action, clinical and translational science","volume":"17","author":"Pang","year":"2024","journal-title":"Clin Transl Sci"},{"issue":"4","key":"10.1016\/j.jor.2026.03.039_bib8","first-page":"CD011535","article-title":"Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis","volume":"4","author":"Sbidian","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.jor.2026.03.039_bib9","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1186\/s13075-019-1938-3","article-title":"Effect of disease-modifying anti-rheumatic drugs on bone structure and strength in psoriatic arthritis patients","volume":"21","author":"Simon","year":"2019","journal-title":"Arthritis Res Ther"},{"issue":"4","key":"10.1016\/j.jor.2026.03.039_bib10","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s12026-023-09366-4","article-title":"Efficacy and safety of IL-23 inhibitors in the treatment of psoriatic arthritis: a meta-analysis based on randomized controlled trials","volume":"71","author":"Huang","year":"2023","journal-title":"Immunol Res"}],"container-title":["Journal of Orthopaedics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0972978X26001406?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0972978X26001406?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T14:08:12Z","timestamp":1789135692000},"score":1,"resource":{"primary":{"URL":"https:\/\/jortho.org\/impact-of-il-23-inhibition-versus-methotrexate-on-select-major-fracture-risk-and-progression-to-joint-arthroplasty-in-psoriatic-patients\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":10,"alternative-id":["S0972978X26001406"],"URL":"https:\/\/doi.org\/10.1016\/j.jor.2026.03.039","relation":{},"ISSN":["0972-978X"],"issn-type":[{"value":"0972-978X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of IL-23 inhibition versus methotrexate on select major fracture risk and progression to joint arthroplasty in psoriatic patients","name":"articletitle","label":"Article Title"},{"value":"Journal of Orthopaedics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jor.2026.03.039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Professor P K Surendran Memorial Education Foundation. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}